부산대학교 도서관

Yuki Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; R&D department, HanaVax Inc., Chiba, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Kurokawa S; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Sugiura K; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Kashima K; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan.; Maruyama S; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan.; Yamanoue T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Honma A; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Mejima M; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Takeyama N; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Research Department, Nisseiken Co., Ltd., Tokyo, Japan.; Kuroda M; Division of Genome Editing Research, National Agriculture and Food Research Organization, Tsukuba, Japan.; Kozuka-Hata H; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Oyama M; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Masumura T; Laboratory of Genetic Engineering, Graduate School of Agriculture, Kyoto Prefectural University, Kyoto, Japan.; Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Fujihashi K; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, United States.; Hiraizumi T; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan.; Goto E; Graduate School of Horticulture, Chiba University, Chiba, Japan.; Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; R&D department, HanaVax Inc., Chiba, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Research Institute of Disaster Medicine, Chiba University Future Medicine Education and Research Organization, Chiba University, Chiba, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States.

Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101568200 Publication Model: eCollection Cited Medium: Print ISSN: 1664-462X (Print) Linking ISSN: 1664462X NLM ISO Abbreviation: Front Plant Sci Subsets: PubMed not MEDLINE

Yuki Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; HanaVax Inc, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. Electronic address: yukiy@ims.u-tokyo.ac.jp.; Harada N; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan.; Sawada SI; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Uchida Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Mori H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Yamanoue T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Machita T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Kanazawa M; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan.; Fukumoto D; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan.; Ohba H; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan.; Miyazaki T; Toko Yakuhin Kogyo Co., Ltd, Japan.; Akiyoshi K; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA.; Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; HanaVax Inc, Tokyo, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Future Medicine Education and Research Organization, Chiba University, Chiba, Japan; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV) Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Umemoto S; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Yuki Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc, Tokyo, Japan.; Kurokawa S; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Machita T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Uchida Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Mori H; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Yamanoue T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Shibata T; Department of Microbiology, Tokyo Medical University, Tokyo, Japan.; Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.; Sawada SI; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.; Ishige K; Biochemicals Division, Yamasa Corporation, Chiba, Japan.; Hirano T; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA.; Akiyoshi K; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.; Kurashima Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Institute for Advanced Academic Research, Chiba University, Chiba, Japan.; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Tokuhara D; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.; Ernst PB; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Division of Comparative Pathology and Medicine, Department of Pathology, University of California, San Diego, CA, USA.; Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan.; Suzuki M; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan.; Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA. kiyono@ims.u-tokyo.ac.jp.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; HanaVax Inc, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.

Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE

Koyanagi K; Department of Preventive and Community Dentistry, Graduate School of Dentistry, Osaka Dental University, 1-8 Kuzuha Hanazono-Cho, Hirakata-Shi, Osaka, 573-1121, Japan.; Kataoka K; Department of Preventive and Community Dentistry, Graduate School of Dentistry, Osaka Dental University, 1-8 Kuzuha Hanazono-Cho, Hirakata-Shi, Osaka, 573-1121, Japan. kataoka-k@tokushima-u.ac.jp.; Department of Oral Health Science and Social Welfare, Graduate School of Oral Sciences, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima-Shi, Tokushima, 770-8504, Japan. kataoka-k@tokushima-u.ac.jp.; Yoshimatsu H; Department of Preventive and Community Dentistry, Graduate School of Dentistry, Osaka Dental University, 1-8 Kuzuha Hanazono-Cho, Hirakata-Shi, Osaka, 573-1121, Japan.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Research Institute of Disaster Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba-Shi, Chiba, Japan.; Division of Mucosal Vaccine, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shiroganedai, Minato-Ku, Tokyo, 108-8639, Japan.; Department of Pediatric Dentistry, School of Dentistry, The University of Alabama at Birmingham, 1919 7Th Avenue South, Birmingham, AL, 35233, USA.; Miyake T; Department of Preventive and Community Dentistry, Graduate School of Dentistry, Osaka Dental University, 1-8 Kuzuha Hanazono-Cho, Hirakata-Shi, Osaka, 573-1121, Japan.

Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831 (Electronic) Linking ISSN: 14726831 NLM ISO Abbreviation: BMC Oral Health Subsets: MEDLINE

Nakahashi-Ouchida R; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA.; Kurashima Y; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan; Institute for Advanced Academic Research, Chiba University, Chiba, Japan; Chiba University-University of California San Diego (CU-UCSD) Center for Mucosal Immunology, Allergy, and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.; Yuki Y; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; HanaVax Inc., Tokyo, Japan.; Kiyono H; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Institute for Advanced Academic Research, Chiba University, Chiba, Japan; Chiba University-University of California San Diego (CU-UCSD) Center for Mucosal Immunology, Allergy, and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA; Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan. Electronic address: hkiyono@chiba-u.jp.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 100966035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-499X (Electronic) Linking ISSN: 14714914 NLM ISO Abbreviation: Trends Mol Med Subsets: MEDLINE

Tsai CJY; Department of Molecular Medicine & Pathology, University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, New Zealand, Auckland.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Japan.; Loh JMS; Department of Molecular Medicine & Pathology, University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, New Zealand, Auckland.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Japan.; Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba, Japan.; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA.; Kiyono H; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Japan.; Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba, Japan.; Institute for Advanced Academic Research, Chiba University, Chiba, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.; Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE

Nakahashi-Ouchida R; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Mori H; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Yuki Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc., Tokyo, Japan.; Umemoto S; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States.; Hirano T; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.; Uchida Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Machita T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Yamanoue T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Sawada SI; Department of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan.; Suzuki M; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.; Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, United States.; Akiyoshi K; Department of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan.; Kurono Y; Department of Otolaryngology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.; Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc., Tokyo, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States.; Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Yuki Y; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Nojima M; Center for Translational Research, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Kashima K; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan.; Sugiura K; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Maruyama S; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan.; Kurokawa S; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Yamanoue T; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Nakahashi-Ouchida R; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.; Nakajima H; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan.; Hiraizumi T; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan.; Kohno H; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan.; Goto E; Graduate School of Horticulture, Chiba University, Chiba, Japan.; Fujihashi K; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA.; Kiyono H; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Future Medicine Education and Research Organization, Chiba University, Chiba, 263-8522, Japan; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV) Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, 92093-0956, USA. Electronic address: kiyono@ims.u-tokyo.ac.jp.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M; Liu, Chenlu; Hashizume, Tomomi; Kurita-Ochiai, Tomoko; Fujihashi, Kohtaro; Yamamoto, Masafumi

Molecular Oral Microbiology. Jun2010, Vol. 25 Issue 3, p178-189. 12p.

Dohi T; Fujihashi K

Current Opinion in Gastroenterology; Nov2006, Vol. 22 Issue 6, p651-657, 7p